State Licensing Due Diligence Before Signing a Distribution Agreement

State licensing should be evaluated before a distribution agreement is signed. Defining each party’s commercial and operational responsibilities early helps identify licensing obligations before they become contractual commitments.

Contracts Do Not Determine Licensing Obligations

State licensing should be assessed before a medical-device distribution agreement fixes the parties’ commercial and operational responsibilities.

A contract may describe one party as the manufacturer, distributor, 3PL, sales agent, or fulfillment provider, but regulators generally examine what each entity actually does.

The agreement can therefore create obligations that neither party identified during negotiations.

Begin With the Intended Distribution Channel

The first question is the intended channel.

Distribution only to licensed practitioners or healthcare facilities may fall within a different permit category—or a narrower exemption—than retail sales, direct-to-patient fulfillment, home-use supply, or sales through independent distributors.

The same device can therefore produce different state outcomes when the channel changes.

Map the Principal Operational Functions

The parties should then map the principal operational functions.

Title and Sale

Identify who owns the inventory, when title transfers, whether inventory is purchased for resale or held on consignment, and which entity controls its disposition.

These facts may distinguish a seller or distributor from a logistics provider acting only on another party’s behalf.

Storage and Shipment

Identify every facility that receives, stores, picks, packs, or ships the product.

A licensed warehouse or 3PL does not necessarily satisfy the separate obligations of the manufacturer, product owner, seller, or invoicing entity.

Orders and Invoicing

Determine which entity accepts orders, approves commercial terms, invoices customers, receives payment, processes returns, and issues credits.

Invoicing is relevant evidence of the commercial role, but it is not an automatic licensing trigger in every state.

In-State Activity

Determine whether either party maintains facilities, inventory, employees, sales representatives, service personnel, or other agents in a state.

Pennsylvania illustrates the need for precision. The registration analysis for an out-of-state seller may change when it employs sales representatives or agents in Pennsylvania.

Registration should not be inferred merely because an out-of-state company invoices or ships to a Pennsylvania customer.

Patient Fulfillment

Direct shipment to a patient may create obligations that do not arise when products move only between commercial facilities.

The parties must identify who receives the patient order, verifies eligibility or prescription information, selects the product, arranges shipment, bills the patient or payer, handles returns, and responds to complaints.

Complete the State-License Matrix Before Execution

The resulting state-license matrix should be completed before execution, not after a launch date has been committed.

The agreement should allocate responsibility for applications, renewals, inspections, fees, recordkeeping, and regulatory cooperation.

Commercial activity in each state should be conditioned on required approvals.

Reassessment should be required when the parties add patient shipment, a new warehouse, consignment inventory, field representatives, a different invoicing entity, or another sales channel.

Resolve Licensing Responsibilities Before Launch

MDD Options can place the manufacturer within its Hybrid distribution model, integrating inventory ownership, order processing, invoicing, regulated distribution, and state licensing.

Where another structure is retained, MDD Options can assess the agreement, identify licensing gaps, and help define corrective actions before execution or launch.